A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer
Status:
Recruiting
Trial end date:
2024-05-30
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, single-arm, phase II study to evaluate the safety and
efficacy of Mitoxantrone Hydrochloride Liposome in patients with advanced HER2 negative
breast cancer.